260 related articles for article (PubMed ID: 12387700)
1. The therapeutic potential of the cannabinoids in neuroprotection.
Grundy RI
Expert Opin Investig Drugs; 2002 Oct; 11(10):1365-74. PubMed ID: 12387700
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids.
López-Rodríguez ML
Mini Rev Med Chem; 2005 Jul; 5(7):607. PubMed ID: 16026306
[No Abstract] [Full Text] [Related]
3. Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects.
Fowler CJ
Brain Res Brain Res Rev; 2003 Jan; 41(1):26-43. PubMed ID: 12505646
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and neuroprotection in motor-related disorders.
de Lago E; Fernández-Ruiz J
CNS Neurol Disord Drug Targets; 2007 Dec; 6(6):377-87. PubMed ID: 18220777
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids and neuroprotection.
Grundy RI; Rabuffetti M; Beltramo M
Mol Neurobiol; 2001; 24(1-3):29-51. PubMed ID: 11831553
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases.
Pérez-Olives C; Rivas-Santisteban R; Lillo J; Navarro G; Franco R
Adv Exp Med Biol; 2021; 1264():81-92. PubMed ID: 33332005
[TBL] [Abstract][Full Text] [Related]
7. The role of cannabinoids in neurodegenerative diseases.
Glass M
Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):743-65. PubMed ID: 11383976
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
Lastres-Becker I; Molina-Holgado F; Ramos JA; Mechoulam R; Fernández-Ruiz J
Neurobiol Dis; 2005; 19(1-2):96-107. PubMed ID: 15837565
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1.
Marsicano G; Moosmann B; Hermann H; Lutz B; Behl C
J Neurochem; 2002 Feb; 80(3):448-56. PubMed ID: 11905991
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids and neuroprotection in basal ganglia disorders.
Sagredo O; García-Arencibia M; de Lago E; Finetti S; Decio A; Fernández-Ruiz J
Mol Neurobiol; 2007 Aug; 36(1):82-91. PubMed ID: 17952653
[TBL] [Abstract][Full Text] [Related]
12. The role of cannabinoids and leptin in neurological diseases.
Agar E
Acta Neurol Scand; 2015 Dec; 132(6):371-80. PubMed ID: 25880465
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids: mechanisms and therapeutic applications in the CNS.
Drysdale AJ; Platt B
Curr Med Chem; 2003 Dec; 10(24):2719-32. PubMed ID: 14529462
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids and neurodegenerative diseases.
Romero J; Orgado JM
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):440-50. PubMed ID: 19839933
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of cannabinoids for movement disorders.
Kluger B; Triolo P; Jones W; Jankovic J
Mov Disord; 2015 Mar; 30(3):313-27. PubMed ID: 25649017
[TBL] [Abstract][Full Text] [Related]
17. Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies.
Fernández-Ruiz J; Gómez-Ruiz M; García C; Hernández M; Ramos JA
Methods Enzymol; 2017; 593():175-198. PubMed ID: 28750802
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids as neuroprotective agents in traumatic brain injury.
Biegon A
Curr Pharm Des; 2004; 10(18):2177-83. PubMed ID: 15281893
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids and cell fate.
Guzmán M; Sánchez C; Galve-Roperh I
Pharmacol Ther; 2002 Aug; 95(2):175-84. PubMed ID: 12182964
[TBL] [Abstract][Full Text] [Related]
20. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
